Curriculum Vitae
Aldina Susana Aragonês da Conceição Pires Reis
Identification
Personal identification
- Full name
- Aldina Susana Aragonês da Conceição Pires Reis
Citation names
- Reis, Aldina
- Reis, Aldina A
- Aldina Reis
- Aldina A Reis
Author identifiers
- Ciência ID
- 0A16-F52E-DD69
- ORCID iD
- 0000-0001-7598-8736
Email addresses
- aldina.reis@estesl.ipl.pt (Professional)
Addresses
- Escola Superior de Tecnologia da Saúde de Lisboa. Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 L, Lisboa, Lisboa, Portugal (Professional)
Knowledge fields
- Medical and Health Sciences - Health Sciences
Education
| Degree | Classification | |
|---|---|---|
|
2013/01/29
Concluded
|
Ciências da Saúde (Doutoramento)
Major in Tecnologias da Saúde
Universidade de Coimbra Faculdade de Medicina, Portugal
"Ganglion Cell and Optic Nerve Physiology in Health and Disease. The Role of Novel Psychophysical and Electrophysiological
Techniques" (THESIS/DISSERTATION)
|
Aprovada com Distinção e Louvor, por Unanimidade |
|
2006/06/23
Concluded
|
Ciências da Visão (DEA)
Major in Oftalmologia
Universidad de Valladolid, Spain
"Alterações de espessura da retina por cirurgia de catarata, registadas por OCT." (THESIS/DISSERTATION)
|
Sobresaliente |
|
2004/10/12
Concluded
|
Ciências da Visão (Mestrado)
Major in Não Aplicável
Universidade de Coimbra Faculdade de Medicina, Portugal
"Avaliação da espessura retiniana por OCT. Estudo comparativo dos valores obtidos pré e pós-cirurgia de catarata." (THESIS/DISSERTATION)
|
Muito Bom por Unanimidade |
|
2001/08/01
Concluded
|
Ortóptica (Licenciatura)
Instituto Politécnico de Lisboa Escola Superior de Tecnologia da Saúde de Lisboa, Portugal
|
18 valores |
|
1995/07/31
Attended
|
Biologia (Licenciatura)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
|
|
|
1989/06/09
Concluded
|
Ortóptica (Bacharelato)
Instituto Politécnico de Coimbra Escola Superior de Tecnologia da Saúde de Coimbra, Portugal
|
17,89 valores |
Affiliation
Science
| Category Host institution |
Employer | |
|---|---|---|
| 2016 - Current | Researcher (Research) | Instituto Politécnico de Lisboa Escola Superior de Tecnologia da Saúde de Lisboa, Portugal |
| Health & Technology Research Center, Portugal | ||
| 2002 - Current | Researcher (Research) | Universidade de Coimbra Faculdade de Medicina, Portugal |
| 1994 - 2015 | Researcher (Research) | Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal |
Teaching in Higher Education
| Category Host institution |
Employer | |
|---|---|---|
| 2016/03/10 - Current | Adjunct Teacher (Polytechnic Teacher) | Instituto Politécnico de Lisboa, Portugal |
| 2004 - 2016 | Invited Adjunct Teacher (Polytechnic Teacher) | Instituto Politécnico de Lisboa Escola Superior de Tecnologia da Saúde de Lisboa, Portugal |
| 2002 - 2004 | Invited Assistant (Polytechnic Teacher) | Instituto Politécnico de Lisboa Escola Superior de Tecnologia da Saúde de Lisboa, Portugal |
Other Careers
| Category Host institution |
Employer | |
|---|---|---|
| 2002 - 2016 | Técnico Especialista (Técnico de Diagnóstico e Terapêutica - Ortoptista) | Centro Hospitalar e Universitario de Coimbra EPE Campus dos Hospitais da Universidade de Coimbra, Portugal |
| 2002 - 2007 | Técnico Principal (Técnico de Diagnóstico e Terapêutica - Ortoptista) | Centro Hospitalar e Universitario de Coimbra EPE Campus dos Hospitais da Universidade de Coimbra, Portugal |
| 1993 - 1997 | Técnico Especialista de 1ª Classe (Técnico de Diagnóstico e Terapêutica - Ortoptista) | Centro Hospitalar e Universitario de Coimbra EPE Campus dos Hospitais da Universidade de Coimbra, Portugal |
| 1989 - 1992 | Técnico de 2ª Classe (Técnico de Diagnóstico e Terapêutica - Ortoptista) | Centro Hospitalar e Universitario de Coimbra EPE Campus dos Hospitais da Universidade de Coimbra, Portugal |
Projects
Contract
| Designation | Funders | |
|---|---|---|
| 2015 - 2017 | CNC.IBILI-Molecular Mechanisms of Brain Diseases / Vision and Brain
UID-NEU/04539/2013
Researcher
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2013/05/01 - 2016/07/15 | European young investigators network for Usher syndrome
E-Rare4/0001/2012
Researcher
Universidade de Coimbra, Portugal
Universidade de Coimbra Faculdade de Medicina, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2013/04/01 - 2015/08/31 | Translational bigenomics investigation in Leber’s Hereditary Optic Neuropathy: Genotype-phenotype correlation
PTDC/DTP-EPI/0929/2012
Researcher
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Universidade de Coimbra, Portugal Centro de Ciências do Mar, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2012 - 2015 | HomeTech-New home automation technologies for healthy and autonomous living for citizens with special needs
Proj. 23218
Researcher
|
Quadro de Referência Estratégico Nacional
Concluded
|
| 2012 - 2015 | EUROCONDOR - Neurodegeneration as an early event in the pathogenesis of DR: A trial to assess the efficacy of neuroprotective
drugs administered topically to prevent or arrest DR
4C-2011-02
|
European Commission Seventh Framework Programme for Research and Technological Development
Concluded
|
| 2010/04/01 - 2014/03/30 | Comprehensive analysis of rod-cone photoreceptor degeneration associated with rhodopsin mutations
E-Rare2/SAU/0001/2008
Researcher
Universidade de Coimbra, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2013 - 2014 | Strategic project UI 3282
PEst-C/SAU/UI3282/2013
Researcher
|
Fundação para a Ciência e a Tecnologia |
| 2012 - 2014 | Data analysis regarding OCT and colour fundus photography in patients with multiple sclerosis
028A
|
|
| 2011 - 2014 | Diamarker – Phenotypes of nonproliferative diabetic retinopathy in diabetes type 2 patients identified by optical coherence
tomography, colour fundus photography, fluorescein leakage and multifocal electrophysiology (DIAMARKER Project: Genetic susceptibility
for multi-systemic complications in diabe
Proj. 13853 / 4C-2011-01
|
Quadro de Referência Estratégico Nacional |
| 2011 - 2013 | BrainEyes - Development of a set of tools for visual diagnosis and rehabilitation, and neurocognitive diagnosis and rehabilitation
Proj. 22133
|
Quadro de Referência Estratégico Nacional |
| 2008 - 2013 | Long term (3 years) ophthalmic safety and cardiac efficacy and safety of ivabradine administered at the therapeutic recommended
doses (2.5/5/7.5 mg b.i.d.) on top of anti anginal background therapy, to patients with chronic stable angina pectoris. An
international, double-blind placebo controlled st
CL3-16257-067
Researcher
|
Les Laboratoires Servier SAS
Concluded
|
| 2009/09/01 - 2012/08/31 | Vision and action processing in neurodevelopmental disorders: from disease mechanisms to new interventional strategies
PIC/IC/82986/2007
Universidade de Coimbra, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2008/04/02 - 2012/04/01 | BIOMOTION: Perception of biological motion - integrating psychophysics, neurophysiology and computational modeling
PTDC/SAU-BEB/68455/2006
Instituto de Engenharia de Sistemas e Computadores, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal Universidade do Minho, Portugal Universidade de Coimbra, Portugal Universidade do Porto Faculdade de Engenharia, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2011 - 2012 | Strategic project UI 3282
PEst-C/SAU/UI3282/2011
Researcher
|
Fundação para a Ciência e a Tecnologia |
| 2008/11/01 - 2011/12/31 | Retinocortical visual processing in normal and pathological aging and neurodevelopment
PTDC/SAU-NEU/68483/2006
Researcher
Instituto Nacional de Engenharia Biomédica, Portugal
Universidade do Minho, Portugal Universidade de Coimbra, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2008/01/01 - 2011/06/30 | SmartVision: active vision for the blind
PTDC/EIA/73633/2006
Universidade do Algarve Centro de Investigação Tecnológica do Algarve, Portugal
Universidade de Lisboa Instituto Superior Técnico, Portugal Universidade de Trás-os-Montes e Alto Douro, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2009 - 2011 | See+Health / Glautech - Development of a prototype for early detection of Glaucoma
Proj. 3512
|
Quadro de Referência Estratégico Nacional |
| 2008 - 2011 | Feedback modulation of visual processing by limbic circuits: a functional connectivity approach to visual face processing
PT/FB/BL-2006-094
Researcher
|
Fundação Bial
Concluded
|
| 2007/11/01 - 2010/11/30 | Neural correlates of object recognition: structure-function correlations within the visual ventral stream, striatal and limbic
circuits in health and disease
PTDC/PSI/67381/2006
Universidade de Aveiro, Portugal
Universidade de Coimbra, Portugal Universidade do Algarve Centro de Investigação Tecnológica do Algarve, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2008 - 2010 | An exploratory, multicenter, patient-masked, dose-escalation, paired-eye comparison, sham-controlled, 6-month (plus 6-month
extension) study to evaluate the safety and effects on visual function of 100 µg, 200 µg and 400 µg brimonidine tartrate posterior
segment drug delivery system (brimonidine tar
190342-028D-01 Brimo RP
|
Allergan Limited
Concluded
|
| 2008 - 2010 | Characterization of early markers of choroidal neovascularization (CNV) in fellow eyes of patients with age-related macular
degeneration and CNV in one eye. Two-year follow-up.
A9011051
Researcher
Pfizer Ltd, United Kingdom
|
Concluded
|
| 2004 - 2010 | Reduction in the occurence of center-threatening diabetic macular edema
B7A-MC-MBDL
Researcher
|
Eli Lilly and Company |
| 2005 - 2009 | EVI-GENORET - Functional genomics of the retina in health and disease
LSHG-CT-2005-512036
Researcher
|
European Commission Sixth Framework Programme for Research and Technological Development
Concluded
|
| 2005 - 2009 | A two-year exploratory, observational, non-interventional multicenter study to identify early markers of choroidal neovascularization
in fellow eyes of patients with neovascular AMD in one eye
CNV-Markers
Researcher
|
Pfizer Portugal |
| 2005/09/01 - 2008/08/31 | Functional mapping of higher order visual and polimodal cortical brain areas
POCI/SAU-NEU/60281/2004
Researcher
Universidade de Coimbra Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2005/06/01 - 2008/05/31 | Structure-function imaging for quantitative phenotyping of retinal degenerations
POSC/EEA-SRI/60716/2004
Researcher
Universidade de Coimbra Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2004 - 2008 | An evaluation of efficacy of posterior juxtascleral administration of anecortave acetate for depot suspension (15 mg or 30
mg) versus sham administrations in patients (enrolled in study “A” or study “B”) at risk for developing sight-threatening
choroidal neovascularization (CNV) due to exudative age
C-02-60
Researcher
|
Alcon Portugal Produtos e Equipamentos Oftalmológicos LDA |
| 2005/10/02 - 2007/12/31 | Biology of human photoreceptors and ganglion cells in health and disease: phenotyping retinal degenerations
POCI/SAU-OBS/57070/2004
Researcher
Universidade de Coimbra Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2004 - 2007 | Multi-modality medical image registration for eye diagnosis
POSI/SRI/45151/2002
Researcher
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2002 - 2007 | An evaluation of efficacy and safety of posterior juxtascleral injections of anecortave acetate 15 mg (0.5 ml of 30 mg/ml
anecortave acetate sterile suspension) versus vehicle in patients with subfoveal choroidal neovascularization (CNV) due to
exudative age-related macular degeneration (AMD)
C-02-27
Researcher
|
Alcon Portugal Produtos e Equipamentos Oftalmológicos LDA
Concluded
|
| 2001 - 2007 | A phase II/III randomized, double-masked, controlled, dose-ranging, multi-centre comparative trial, in parallel groups, to
establish the safety and efficacy of intravitreal injections of eye001 (anti-VEGF pegylated aptamer) given every 6 weeks for
54 weeks, in patients with exudative age-related mac
EOP1003
Researcher
|
Bausch Health Companies Inc US |
| 2003 - 2005 | A phase II randomized, controlled, double-masked, dose-finding, multi-centre, comparative trial, in parallel groups, to establish
the safety and preliminary efficacy of intravitreal injections of Eye001 (anti-VEGF Pegylated Aptamer), given every 6 weeks
for 12 to 30 weeks, to patients with clinical
EOP1005
Researcher
|
Bausch Health Companies Inc US |
| 2003 - 2004 | Comparison of the efficacy and safety of unpreserved dexamethasone phosphate 0.1% eye drops versus preserved dexamethasone
sodium phosphate 0.1% eye drops in controlling post-operative inflammation after cataract surgery. Evaluation using a Laser
Flare Meter
LT1910-T02F0301
Researcher
|
Concluded
|
Outputs
Publications
| Journal article |
|
| Thesis / Dissertation |
|